You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info

Xpert® HCV VL Fingerstick

Detection and quantitation of Hepatitis C virus (HCV) in about an hour

Product Resources MyCepheid Store
Xpert<sup>®</sup>&nbsp;HCV VL Fingerstick
#carousel-featured_content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-featured_content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VIDEO

London Pharmacy Video - Xpert HCV VL Fingerstick - Near Patient Testing for Hepatitis C

The WHO has set a goal to eliminate Hepatitis C by 2030. England will strive for 2025.

Watch Video

Video Image

The Goal

Elimination of Hepatitis C by 2030

Viral hepatitis is one of the leading causes of death globally with 1.34 million deaths per year, as many as HIV/AIDS, tuberculosis or malaria. Both hepatitis B and C viruses cause 80% of liver cancer cases in the world.1

The WHO global health sector strategy to eliminate Viral Hepatitis C as a major public health threat by 2030 identifies the key role of diagnostics and linkage to care.2

  • Individuals at highest risk of transmitting HCV, such as people who inject drugs, prisoners, and men who have sex with men, have poor access to testing and therefore treatment.2
  • Complicated multi-step diagnostic pathways based on antibody screening and RNA confirmation take time and represent barriers that discourage at risk populations from testing.3,4,5

The Need

Simplification of the diagnostic pathway to improve linkage to care

  • Until now, confirmation of a positive antibody-based test requires venepuncture, preparation and transport of blood specimens, laboratory expertise, and days/weeks to obtain results.4
  • A final diagnosis of active HCV infection may require up to 5 visits.3
  • A simple one-step pathway, with a fast RNA diagnostic at the point of care, may have the potential to simplify testing algorithms, increase diagnosis rates, and lead to increased linkage to care.

(1) Mohd Hanafiah K, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57(4): 1333-42.
(2) WHO. Hepatitis C Fact Sheet N° 164. Updated April 2014. Accessed April 2015 at http://www.who.int/mediacentre/factsheets/fs164/en/;
(3) Ghany MG, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009 Apr;49 (4):1335-74.
(4) Graham CS, et al. A Path to Eradication of Hepatitis C in Low-and-Middle-Income Countries. Antiviral Res. 2015 Jan 20; pii: S0166-3542(15)00005-4. [Epub ahead of print].

The Solution

Xpert HCV VL Fingerstick on the GeneXpert® System

  • Collect a drop of blood via fingerstick, transfer the blood to a test cartridge and run the test.
  • Fast diagnosis of HCV RNA from capillary whole blood and venous blood samples
  • Flexible and portable system, thanks to a cartridge-based design.
  • Quantitative RNA results available in less than 1 hour at the point of care.

Ordering Info

Xpert® HCV VL Fingerstick

Number of Tests: 10

Catalog #: GXHCV-FS-CE-10

Xpert® HCV VL Fingerstick

Collection Device – Minivette Number per Pack: 100

Catalog #: Minivette100E-100

Educational Materials

#carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
Jason Grebely Webinar
WEBINAR

Jason Grebely Webinar

Testing Process Video
VIDEO

Testing Process Video

Prison Health
DOCUMENT

Prison Health

Finding Active Cases Early in the 'World Behind the Walls'

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay
DOCUMENT

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

Lamoury et al., 2018 – J Infect Diseases May, 2018

The Xpert HCV Viral Load Finger-Stick
DOCUMENT

The Xpert HCV Viral Load Finger-Stick

Fekete T, et al. – Ann Intern Med. 2018 Sep 18;169(6):JC35.

Acceptability and preferences of point-of-care finger-stick whole-blood
DOCUMENT

Acceptability and preferences of point-of-care finger-stick whole-blood

Bajis etal. – Int J Drug Policy. 2018 Nov;61:23-30.

Back to Top